Literature DB >> 9915961

Rapid clearance of fetal DNA from maternal plasma.

Y M Lo1, J Zhang, T N Leung, T K Lau, A M Chang, N M Hjelm.   

Abstract

Fetal DNA has been detected in maternal plasma during pregnancy. We investigated the clearance of circulating fetal DNA after delivery, using quantitative PCR analysis of the sex-determining region Y gene as a marker for male fetuses. We analyzed plasma samples from 12 women 1-42 d after delivery of male babies and found that circulating fetal DNA was undetectable by day 1 after delivery. To obtain a higher time-resolution picture of fetal DNA clearance, we performed serial sampling of eight women, which indicated that most women (seven) had undetectable levels of circulating fetal DNA by 2 h postpartum. The mean half-life for circulating fetal DNA was 16.3 min (range 4-30 min). Plasma nucleases were found to account for only part of the clearance of plasma fetal DNA. The rapid turnover of circulating DNA suggests that plasma DNA analysis may be less susceptible to false-positive results, which result from carryover from previous pregnancies, than is the detection of fetal cells in maternal blood; also, rapid turnover may be useful for the monitoring of feto-maternal events with rapid dynamics. These results also may have implications for the study of other types of nonhost DNA in plasma, such as circulating tumor-derived and graft-derived DNA in oncology and transplant patients, respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9915961      PMCID: PMC1377720          DOI: 10.1086/302205

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  32 in total

1.  Fate of injected deoxyribonucleic acid in mice.

Authors:  T TSUMITA; M IWANAGA
Journal:  Nature       Date:  1963-06-15       Impact factor: 49.962

2.  Blood nucleases and infectious viral nucleic acids.

Authors:  R M HERRIOTT; J H CONNOLLY; S GUPTA
Journal:  Nature       Date:  1961-03-11       Impact factor: 49.962

3.  Prenatal sex determination by DNA amplification from maternal peripheral blood.

Authors:  Y M Lo; P Patel; J S Wainscoat; M Sampietro; M D Gillmer; K A Fleming
Journal:  Lancet       Date:  1989-12-09       Impact factor: 79.321

4.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

5.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

6.  Practical and theoretical implications of fetal-maternal lymphocyte transfer.

Authors:  J Walknowska; F A Conte; M M Grumbach
Journal:  Lancet       Date:  1969-06-07       Impact factor: 79.321

7.  The clearance and localization of nucleic acids by New Zealand and normal mice.

Authors:  T M Chused; A D Steinberg; N Talal
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

8.  Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions.

Authors:  M C Longo; M S Berninger; J L Hartley
Journal:  Gene       Date:  1990-09-01       Impact factor: 3.688

9.  Isolation of fetal DNA from nucleated erythrocytes in maternal blood.

Authors:  D W Bianchi; A F Flint; M F Pizzimenti; J H Knoll; S A Latt
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

10.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase.

Authors:  P M Holland; R D Abramson; R Watson; D H Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

View more
  254 in total

1.  Noninvasive whole-genome sequencing of a human fetus.

Authors:  Jacob O Kitzman; Matthew W Snyder; Mario Ventura; Alexandra P Lewis; Ruolan Qiu; Lavone E Simmons; Hilary S Gammill; Craig E Rubens; Donna A Santillan; Jeffrey C Murray; Holly K Tabor; Michael J Bamshad; Evan E Eichler; Jay Shendure
Journal:  Sci Transl Med       Date:  2012-06-06       Impact factor: 17.956

2.  Prospective assessment of fetal-maternal cell transfer in miscarriage and pregnancy termination.

Authors:  S E Peterson; J L Nelson; K A Guthrie; V K Gadi; T M Aydelotte; D J Oyer; S W Prager; H S Gammill
Journal:  Hum Reprod       Date:  2012-06-29       Impact factor: 6.918

3.  MALDI-TOF MS in Prenatal Genomics.

Authors:  Xiao Yan Zhong; Wolfgang Holzgreve
Journal:  Transfus Med Hemother       Date:  2009-06-25       Impact factor: 3.747

Review 4.  Cell-free fetal nucleic acids in amniotic fluid.

Authors:  L Hui; D W Bianchi
Journal:  Hum Reprod Update       Date:  2010-10-05       Impact factor: 15.610

5.  Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors.

Authors:  David J McBride; Arto K Orpana; Christos Sotiriou; Heikki Joensuu; Philip J Stephens; Laura J Mudie; Eija Hämäläinen; Lucy A Stebbings; Leif C Andersson; Adrienne M Flanagan; Virginie Durbecq; Michail Ignatiadis; Olli Kallioniemi; Caroline A Heckman; Kari Alitalo; Henrik Edgren; P Andrew Futreal; Michael R Stratton; Peter J Campbell
Journal:  Genes Chromosomes Cancer       Date:  2010-11       Impact factor: 5.006

6.  Non-invasive prenatal paternity testing from maternal blood.

Authors:  Jasenka Wagner; Snjezana Dzijan; Damir Marjanović; Gordan Lauc
Journal:  Int J Legal Med       Date:  2008-10-24       Impact factor: 2.686

7.  Liquid Biopsy in Breast Cancer: Circulating Tumor Cells and Circulating Tumor DNA.

Authors:  Tae-Kyung Yoo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Fetal DNA in maternal serum: does it persist after pregnancy?

Authors:  Alexandra Benachi; Julie Steffann; Evelyne Gautier; Pauline Ernault; Martine Olivi; Yves Dumez; Jean-Marc Costa
Journal:  Hum Genet       Date:  2003-03-15       Impact factor: 4.132

Review 9.  Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.

Authors:  Kathryn J Gray; Louise E Wilkins-Haug
Journal:  Pediatr Radiol       Date:  2018-03-17

Review 10.  Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation.

Authors:  Matthew R Grace; Emily Hardisty; Sarah K Dotters-Katz; Neeta L Vora; Jeffrey A Kuller
Journal:  Obstet Gynecol Surv       Date:  2016-08       Impact factor: 2.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.